Articles producció científica> Medicina i Cirurgia

Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting

  • Identification data

    Identifier: imarina:5878804
    Handle: http://hdl.handle.net/20.500.11797/imarina5878804
  • Authors:

    Imbimbo M, Maury JM, Garassino M, Girard N, RARECAREnet Working Group
  • Others:

    Author, as appears in the article.: Imbimbo M, Maury JM, Garassino M, Girard N, RARECAREnet Working Group
    Department: Medicina i Cirurgia
    URV's Author/s: Galceran Padrós, Jaume Josep Maria
    Keywords: @infoAeu @residentesaeu @uroweb Etiqueta «#» Hashtag
    Abstract: © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology The management of patients with mesothelioma and thymic malignancy requires continuous multidisciplinary expertise at any step of the disease. A dramatic improvement in our knowledge has occurred in the last few years, through the development of databases, translational research programs, and clinical trials. Access to innovative strategies represents a major challenge, as there is a lack of funding for clinical research in rare cancers and their rarity precludes the design of robust clinical trials that could lead to specific approval of drugs. In this context, patient-centered initiatives, such as the establishment of dedicated networks, are warranted. International societies, such as IMIG (International Mesothelioma Interest Group) and ITMIG (International Thymic Malignancy Interest Group) provide infrastructure for global collaboration, and there are many advantages to having strong regional groups working on the same issues. There may be regional differences in risk factors, susceptibility, management and outcomes. The ability to address questions both regionally as well as globally is ideal to develop a full understanding of mesothelioma and thymic malignancies. In Europe, through the integration of national networks with EURACAN, the collaboration with academic societies and international groups, the development of networks in thoracic oncology provides multiplex integration of clinical care and research, ultimately ensuring equal access to high quality care to all patients, with the opportunity of conducting high level clinical and translational research projects.
    Thematic Areas: Surgery Oncology Medicine (miscellaneous) Medicina iii Medicina ii Medicina i General medicine Enfermagem
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 07487983
    Author's mail: jaumejosepmaria.galceran@urv.cat
    Record's date: 2023-02-18
    Papper version: info:eu-repo/semantics/acceptedVersion
    Link to the original source: https://www.ejso.com/article/S0748-7983(18)30114-8/fulltext
    Licence document URL: http://repositori.urv.cat/ca/proteccio-de-dades/
    Papper original source: Ejso. 45 (1): 75-80
    APA: Imbimbo M, Maury JM, Garassino M, Girard N, RARECAREnet Working Group (2019). Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Ejso, 45(1), 75-80. DOI: 10.1016/j.ejso.2018.01.078
    Article's DOI: 10.1016/j.ejso.2018.01.078
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2019
    Publication Type: Journal Publications
  • Keywords:

    Medicine (Miscellaneous),Oncology,Surgery
    Surgery
    Oncology
    Medicine (miscellaneous)
    Medicina iii
    Medicina ii
    Medicina i
    General medicine
    Enfermagem
  • Documents:

  • Cerca a google

    Search to google scholar